The cost-effectiveness and budgetary impact of a dolutegravir-based regimen as first-line treatment of HIV infection in India.
about
The cost-effectiveness and budgetary impact of a dolutegravir-based regimen as first-line treatment of HIV infection in India.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
The cost-effectiveness and bud ...... ent of HIV infection in India.
@en
The cost-effectiveness and bud ...... ent of HIV infection in India.
@nl
type
label
The cost-effectiveness and bud ...... ent of HIV infection in India.
@en
The cost-effectiveness and bud ...... ent of HIV infection in India.
@nl
prefLabel
The cost-effectiveness and bud ...... ent of HIV infection in India.
@en
The cost-effectiveness and bud ...... ent of HIV infection in India.
@nl
P2093
P2860
P50
P356
P1476
The cost-effectiveness and bud ...... ent of HIV infection in India.
@en
P2093
A David Paltiel
Bharat B Rewari
Mingshu Huang
Rochelle P Walensky
P2860
P304
P356
10.1002/JIA2.25085
P577
2018-03-01T00:00:00Z